Syngenta Faces Second Lawsuit Over Agrisure Viptera Corn Seed

A second company has sued Syngenta AG over sales of genetically modified corn seed not approved by China, raising the stakes for the Swiss-based seed maker by including byproducts used for animal feed in its complaint and seeking class-action status, reports Tom Polansek on Reuters.com.

Trans Coastal Supply Co, a major exporter of livestock feed products, said in court documents it expects to lose more than $41 million because Syngenta sold Agrisure Viptera corn seed, known as MIR 162, to U.S. farmers without first obtaining import approval from Beijing.

On Friday, international trader Cargill Inc. charged in a lawsuit that Syngenta exposed the agribusiness company to more than $90 million in losses by selling the trait in corn seed without China’s approval for imports.

Top Articles
Cultivating Tomorrow: GROWERS CEO on How Harnessing Transactional Data Can Enhance Customer Loyalty in 2025

China, a major buyer of U.S. grains, has rejected boatloads of U.S. crops containing the variety over the past year.

The majority of Illinois-based Trans Coastal’s losses are related to exports of an ethanol byproduct called distillers dried grains (DDGs), used in livestock feed, according to court documents filed on Friday in federal court in Urbana, IL.

Cargill said its losses were linked to rejections of U.S. corn.

Syngenta spokesman Paul Minehart said the lawsuits filed by both companies are without merit.

Trans Coastal’s complaint highlights traders’ concerns that MIR 162 can be found throughout the U.S. corn supply chain — from seed planted in farmers’ fields to the byproduct of ethanol production.

Syngenta invested about $200 million and five to seven years developing MIR 162 corn and “selfishly” decided to rush it to market without obtaining China’s approval for imports in a bid to recoup its costs, the lawsuit states. The trait represents about 25 percent of the Swiss-based seed maker’s corn portfolio, according to court documents.

Read the full story on Reuters.com.

0
Advertisement